EpiVax Secures Additional Funding from FDA for Immunogenicity ...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
PROVIDENCE, R.I., Sept. 12, 2022 /PRNewswire-AsiaNet/ -- EpiVax, Inc. ("EpiVax") is pleased to announce the award of a two-year, $2 million grant from the FDA's Office of Center for Drug Evaluation and Research (CDER) to validate a method for immunogenicity risk assessment of host cell proteins (HCP) fo...
Authors: LATEST ASIANET NEWS RELEASES